Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

New Zealand

Medsafe assesses quality, safety and efficacy, while Pharmac can begin funding assessment in parallel. Pharmac obtains clinical advice, evaluates and compares options, negotiates, consults and decides whether to list a medicine on the Pharmaceutical Schedule.

Medsafe
Pharmac / PharmConnect
PTAC / advisory committees
Pharmac / supplier
Pharmac
6 decision nodes14 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it